Lake Julie-anne, Carr Jillian, Feng Feng, Mundy Linda, Burrell Christopher, Li Peng
National Centre for HIV Virology Research, Infectious Diseases Laboratories, Institute of Medical and Veterinary Science, Frome Road, Adelaide 5000, Australia.
J Clin Virol. 2003 Feb;26(2):143-52. doi: 10.1016/s1386-6532(02)00113-0.
Current research suggests that human immunodeficiency virus type-1 (HIV-1) virion infectivity factor (Vif) acts during viral assembly in producer cells to ensure infectivity in target cells but the exact mechanism of action has not been defined. Vif interacts with Gag, viral protease and RNA and these interactions are proposed to be important for correct particle assembly and stability of the reverse transcription complex.
The existence of cells that are either permissive or non-permissive for replication of Vif deficient viruses suggests the involvement of host cellular factors in its function. Current research suggests an association of Vif with the intermediate filament protein, vimentin, and the tyrosine kinase, Hck, but the significance of these associations remains to be defined. More recently HP68, a cellular ATP binding protein, has been shown to be important for capsid formation and an interaction between Vif and HP68 has been shown. Our aim was to further identify host cellular factors involved in Vif function.
We have employed the yeast 2-hybrid system to identify cellular proteins which interact with HIV-1 Vif. Sixteen clones were isolated from a high stringency yeast-2-hybrid screen of a human leucocyte cDNA library with Vif derived from the T-cell tropic HIV-1 strain NL4.3. Of these, 8 clones were confirmed as specifically binding Vif, fully sequenced and identified via GenBank homology searches.
Thus far 3 of these clones, spermine/spermidine N1-acetyltransferase, Triad 3 and a novel gene which we have termed 'novel Vif binding protein', have been characterised and represent attractive candidates for mediating Vif action during HIV replication.
Through identification and characterisation of cellular factors interacting with HIV-1 Vif we hope to unravel the mechanism of action of Vif which may ultimately aid therapeutic design.
当前研究表明,1型人类免疫缺陷病毒(HIV-1)的病毒体感染性因子(Vif)在病毒产生细胞的组装过程中发挥作用,以确保在靶细胞中的感染性,但具体作用机制尚未明确。Vif与Gag、病毒蛋白酶和RNA相互作用,这些相互作用被认为对正确的颗粒组装和逆转录复合物的稳定性很重要。
对Vif缺陷病毒复制允许或不允许的细胞的存在表明宿主细胞因子参与了其功能。当前研究表明Vif与中间丝蛋白波形蛋白和酪氨酸激酶Hck有关联,但这些关联的意义仍有待确定。最近,一种细胞ATP结合蛋白HP68已被证明对衣壳形成很重要,并且已显示Vif与HP68之间存在相互作用。我们的目的是进一步鉴定参与Vif功能的宿主细胞因子。
我们利用酵母双杂交系统来鉴定与HIV-1 Vif相互作用的细胞蛋白。从用人白细胞cDNA文库进行的高严谨度酵母双杂交筛选中分离出16个克隆,该文库用来自嗜T细胞HIV-1株NL4.3的Vif进行筛选。其中,8个克隆被确认为特异性结合Vif,进行了全序列测定并通过GenBank同源性搜索进行了鉴定。
到目前为止,这些克隆中的3个,即精胺/亚精胺N1-乙酰转移酶、三联体3和一个我们称为“新型Vif结合蛋白”的新基因,已得到表征,是HIV复制过程中介导Vif作用的有吸引力的候选者。
通过鉴定和表征与HIV-1 Vif相互作用的细胞因子,我们希望阐明Vif的作用机制,这最终可能有助于治疗设计。